Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Depressive Disorder, Treatment-Resistant × Infliximab × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 3 Colitis 3 Carcinoma, Non-Small-Cell Lung 3 Urogenital Neoplasms 2 Depressive Disorder, Major 2 Depression 2 Vasculitis 1 Stroke 1 Skin Neoplasms 1 Lung Neoplasms 1 Kidney Transplantation 1 Inflammation 1 Hematologic Neoplasms 1 Drug-Related Side Effects and Adverse Reactions 1 Depressive Disorder, Treatment-Resistant 1 Colitis, Ulcerative 1 Cognitive Dysfunction 1 Bipolar Disorder 1 Aneurysm 1

Interventions

Saline Solution 1 Infliximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00463580 2025-07-08

Infliximab

Emory University

Phase 4 Completed

60 enrolled 15 charts

Bipolar Disorder, Depression, Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡